Health systems are moving quickly from artificial intelligence (AI) experimentation to deployment. Executive teams are evaluating copilots, ambient documentation, predictive models, and agentic AI platforms that can identify patients, recommend interventions, coordinate care, close quality gaps, and support operational decisions. But that progress raises a foundational question: How confident are health systems that every agent is identifying the right patients? The answer depends not only on the AI, but also on the quality and consistency of the patient cohorts it uses.
Most organizations have spent years building patient cohorts, value sets, registries, and groupers for specific reporting, operational, and clinical purposes. Different departments used different code systems and governance processes, creating overlapping definitions across the enterprise.
Historically, that sprawl led to reporting inefficiencies and analytic discrepancies. As agents begin acting on those definitions, it can also shape how patients are identified, prioritized, and managed.
Why patient cohorts are the foundation of agentic AI in healthcare
Patient cohorts are no longer just behind-the-scenes assets for quality reporting, care management, population health analytics, and research. They are becoming the foundation for AI-enabled workflows, which means the quality of cohort definitions can directly affect downstream recommendations, decisions, and actions.
Consider a heart failure outreach agent. Before it can identify care gaps, it must determine which patients have heart failure. The same is true for a quality-measure agent identifying an eligible population before recommending interventions or a readmission prevention agent determining who belongs in a target cohort before assessing risk. Each workflow depends on the accuracy of the underlying patient definition.
If that cohort is incomplete, inconsistent, or outdated, the workflow begins with a flawed foundation. And model sophistication cannot fully compensate for uncertainty about which patients belong in the population.
What happens when AI agents use different clinical definitions?
Yet many health systems do not maintain a single, governed definition for their most important clinical populations. Growth, acquisitions, departmental autonomy, and changing reporting requirements have allowed multiple definitions of the same condition to coexist.
For heart failure, one team may use ICD-10-CM diagnosis codes, another may rely on SNOMED® concepts, a third may incorporate medication-based logic, and a fourth may use a custom grouper developed years ago. Each definition may appear reasonable on its own, yet each can produce a different patient population and a different answer about who should receive an intervention.
This challenge is not hypothetical. One health system working with IMO Health identified approximately 75 to 78 heart failure-related groupers, with limited visibility into their overlap, ownership, clinical intent, or differences.
Now imagine five AI agents relying on five definitions of heart failure. Different agents may identify different patients, trigger different interventions, and recommend different actions for what is intended to be the same clinical population. A reporting inconsistency has become a workflow inconsistency.
Keeping pace with healthcare AI
AI deployment is moving faster than cohort governance. Building an agent is becoming more straightforward, but establishing trusted enterprise definitions still requires cross-functional governance, clinical consensus, and ongoing stewardship.
Many organizations have governance frameworks for cybersecurity, privacy, and model oversight. Fewer have established comparable processes for patient cohorts, value sets, and clinical definitions, even though these assets determine what an agent sees, evaluates, and ultimately acts upon.
Without governance, familiar challenges persist:
- Duplicate or overlapping definitions
- Unclear ownership and clinical intent
- Manual or inconsistent maintenance
- Inconsistent code-system usage
- Difficulty explaining why a patient entered a workflow
These issues predate AI. Agentic workflows make them more visible and consequential.
Why trustworthy AI depends on governed patient cohorts
AI governance often focuses on models, prompts, hallucinations, and explainability. Those issues matter, but organizations must also trust which patients an agent is evaluating.
A governed cohort framework gives agents an authoritative, clinically reviewed source of truth. Instead of determining who belongs in a population each time a workflow is built, teams can maintain validated definitions over time and reuse them across agents, analytics platforms, and operational processes. This reduces the need to repeatedly rebuild and validate the same clinical logic.
That common foundation supports consistency, explainability, auditability, and more reliable workflows because each agent begins with the same trusted understanding of the population.
Are your patient cohorts ready for agentic AI?
Cohort governance is not a future cleanup exercise. As more AI-enabled processes are built, inconsistent definitions become embedded across agents, reports, dashboards, and operational workflows. At that point, rationalizing cohorts requires teams to unwind clinical logic from multiple systems and processes, making the work substantially harder.
As agentic AI adoption accelerates, governed patient cohorts are becoming a strategic AI-readiness requirement and a foundational component of enterprise AI governance.
This is not simply data cleanup. It is the work of establishing a dependable clinical foundation before automation scales. Before health systems ask what their agents can do, they should ask a more fundamental question: Do we trust the clinical definitions those agents will use to identify the right patients?
